Global Protein Therapeutics Market

Protein Therapeutics Market Size, Share, Growth Analysis, By Product Type(Monoclonal Antibodies, Insulin, Vaccines, Growth Hormones), By Application(Oncology, Hematology, Immunology, Metabolic Disorders), By Therapeutic Area(Cancer, Diabetes, Infectious Diseases, Autoimmune Disorders), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2238 | Region: Global | Published Date: March, 2024
Pages: 219 |Tables: 99 |Figures: 76

Protein Therapeutics Market Insights

Global Protein Therapeutics Market size was valued at USD 6.57 billion in 2022 and is poised to grow from USD 6.96 billion in 2023 to USD 11.10 billion by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

The global Protein Therapeutics market is witnessing tremendous growth driven by the expanding field of biopharmaceuticals and the growing occurrence of persistent diseases. Protein therapeutics, which include monoclonal antibodies, insulin, and vaccines, continue to play a pivotal function in the treatment of numerous clinical situations. Advancements in biotechnology, coupled with the development of modern protein-based capsules, make contributions to the market's momentum.

Additionally, the developing adoption of personalized medicine and focused treatment plans further fuels the call for. Challenges include excessive production prices and regulatory complexities. North America dominates the market, with Asia-Pacific emerging as a rapidly developing location due to increased healthcare infrastructure and growing patient populations. Key developments consist of the exploration of novel healing targets and the mixing of superior technology in protein healing development.

Market Snapshot - 2024-2031

Global Market Size

USD 6.57 billion

Largest Segment

Monoclonal Antibodies

Fastest Growth

Vaccines

Growth Rate

6% CAGR

Global Protein Therapeutics Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Protein Therapeutics Market Segmental Analysis

The global Protein Therapeutics market is segmented into four major segments i.e. by Product Type, Application, Therapeutic Area, and region. Based on Type, it is divided into Monoclonal Antibodies, Insulin, Vaccines, Growth Hormones, Blood Clotting Factors, Enzyme Replacement Therapies. Based on Application, it is bifurcated as Oncology, Hematology, Immunology, Metabolic Disorders, Cardiovascular Disorders, Others. Based on Therapeutic Area it is segregated into Cancer, Diabetes, Infectious Diseases, Autoimmune Disorders, Genetic Disorders, and Others. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.

Analysis by Type

Monoclonal Antibodies (mAbs) are likely to dominate the market. MAbs have received prominence because of their specificity in concentrating on various illnesses, inclusive of cancer and autoimmune disorders. The massive adoption of mAbs across therapeutic regions contributes to their dominance, as they stay a cornerstone in biopharmaceuticals.

Vaccines can be the quickest-growing product kind. The international emphasis on preventive healthcare and the continued improvement of novel vaccines for rising infectious illnesses contribute to the increasing call for. Additionally, advancements in vaccine technologies, along with mRNA vaccines, further force increase, making vaccines an unexpectedly evolving and critical phase in the Protein Therapeutics marketplace.

Analysis by Application

Oncology is probably to dominate the marketplace. The widespread prevalence of cancer and the growing use of protein therapeutics, mainly monoclonal antibodies, in cancer treatment contribute to the dominance of the oncology segment. The non-stop improvement of targeted healing procedures for various cancers similarly reinforces the prominence of protein therapeutics in oncology.

Immunology can be the fastest-developing software section. The rising prevalence of autoimmune issues and the development of protein therapeutics targeting the immune machine have contributions to the growth of this segment. Advancements in knowledge of the immunological foundation of illnesses and the improvement of biologics for conditions like rheumatoid arthritis and inflammatory bowel ailment are using the rapid growth of immunology as a key software location.

Global Protein Therapeutics Market By Type, 2022 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Protein Therapeutics Market Regional Insights

North America is likely to dominate the Protein Therapeutics market. This dominance is attributed to the area's properly-set up biopharmaceutical industry, enormous studies and development sports, and a high incidence of chronic illnesses. The presence of key marketplace players and a robust healthcare infrastructure in addition contribute to North America's leadership within the Protein Therapeutics marketplace.

Asia-Pacific can be the fastest-developing vicinity. The Asia-Pacific place is experiencing a surge in biopharmaceutical studies and production sports, supported via a developing cognizance on healthcare infrastructure and increasing investment inside the lifestyles sciences region. Additionally, the rising healthcare expenditure, a large affected person population, and increasing awareness of superior therapies make contributions to the speedy boom of the Protein Therapeutics marketplace in Asia-Pacific.

Global Protein Therapeutics Market By Region, 2024-2031
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Protein Therapeutics Market Dynamics

Drivers

Increasing Prevalence of Chronic Diseases

  • The growing prevalence of continual illnesses and complicated clinical conditions, for which protein-primarily based treatment options provide targeted and effective treatment options. The versatility of protein therapeutics, such as monoclonal antibodies and other biologics, allows precise interventions in numerous healing regions, which includes oncology, immunology, and metabolic problems. Additionally, improvements in biotechnology and genetic engineering have facilitated the development of revolutionary and stronger protein therapeutics. The growing trend closer to personalized remedy and the call for biopharmaceuticals with fewer side results similarly stimulate the adoption of protein-based totally remedies.

Restraints

High Cost Associated with the Development

One of the primary marketplace restraints is the excessive fee associated with the improvement, manufacturing, and commercialization of protein-primarily based treatment plans. The elaborate manufacturing procedures and the need for advanced technologies make a contribution to multiplied costs, proscribing accessibility, specifically in less prosperous areas. Additionally, regulatory complexities and stringent approval tactics pose challenges, delaying the time-to-marketplace for protein therapeutics. Immunogenicity worries, wherein the patient's immune gadget might also develop a reaction to the therapeutic protein, also present hurdles.

Request Free Customization of this report to help us to meet your business objectives.

Protein Therapeutics Market Competitive Landscape

The aggressive environment of the Protein Therapeutics market is dynamic and characterised with the aid of the presence of key gamers and a dynamic interaction of innovation and strategic collaborations. The market also sees contributions from emerging biotech corporations centered on developing novel protein-based total capsules, fostering a weather of continuous studies and improvement. Strategic partnerships, mergers, and acquisitions are not unusual techniques hired to beautify product pipelines and extend market reach. Additionally, biosimilar opposition is intensifying, as businesses goal to provide cost-effective alternatives to installed protein therapeutics.

Top Player’s Company Profiles

  • Amgen Inc. (US)
  • AbbVie Inc. (US)
  • Roche Diagnostics (Switzerland)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • Pfizer Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (US)
  • Celgene Corporation (US)
  • GlaxoSmithKline PLC (UK)
  • Gilead Sciences, Inc. (US)
  • Biogen Inc. (US)
  • AstraZeneca PLC (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Abbott Laboratories (US)
  • Bayer AG (Germany)
  • Alexion Pharmaceuticals Inc. (US)
  • Novartis AG (Switzerland)
  • Sanofi (France)

Recent Developments

  • December 2023: AbbVie is set to expand its presence in neuroscience and psychiatry with its $8.7 billion acquisition of Cerevel Therapeutics. Despite holding a wealth of neuroscience assets, the move gives AbbVie a valuable plus: access to a Phase 2 trial treatment for schizophrenia, further strengthening its position in the industry.
  • October 2023: Lilly has entered into an agreement to acquire its collaborator, Mablink Bioscience, enhancing its portfolio with additional ADC technology and drug applications. This acquisition strengthens Lilly's position within the thriving subject of cancer therapeutics. Mablink, established in France, is advancing a pipeline based totally on PSARLink, a linker generation aimed at minimizing systemic toxicity and augmenting the centered transport of healing payloads to cancer cells.

Protein Therapeutics Key Market Trends

  • Rising Emphasis on Personalized Medicine: The growing emphasis on personalised remedy, with a growing attention on developing focused protein therapeutics tailor-made to individual affected person profiles. The rise of subsequent-technology biologics, consisting of antibody-drug conjugates and bispecific antibodies, underscores a trend towards more potent and versatile therapeutic modalities. Furthermore, improvements in protein engineering technology are facilitating the layout of novel and optimized protein systems, enhancing healing efficacy. The exploration of opportunity management routes, which include subcutaneous and oral transport, is gaining traction, presenting progressed affected person convenience.

Protein Therapeutics Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

Global Protein Therapeutics market analysis exhibits a dynamic market with some standout developments and problems. The marketplace is pushed by way of the escalating occurrence of chronic illnesses and advancements in biotechnology, fostering the improvement of progressive healing procedures. However, high manufacturing fees and regulatory demanding situations act as restraints. Monoclonal antibodies dominate the product landscape, addressing various therapeutic regions.

North America leads because of a mature biopharmaceutical industry. Key developments include the exploration of customized medication, the emergence of subsequent-era biologics, and a focus on biosimilars for improved remedy accessibility. These factors together form a dynamic panorama, promising persevered advancements in protein-based healing interventions.

Report Metric Details
Market size value in 2022 USD 6.57 billion
Market size value in 2031 USD 11.10 billion
Growth Rate 6%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product Type
    • Monoclonal Antibodies, Insulin, Vaccines, Growth Hormones, Blood Clotting Factors, Enzyme Replacement Therapies
  • Application
    • Oncology, Hematology, Immunology, Metabolic Disorders, Cardiovascular Disorders, Others
  • Therapeutic Area
    • Cancer, Diabetes, Infectious Diseases, Autoimmune Disorders, Genetic Disorders, Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Amgen Inc. (US)
  • AbbVie Inc. (US)
  • Roche Diagnostics (Switzerland)
  • Eli Lilly and Company (US)
  • Johnson & Johnson (US)
  • Pfizer Inc. (US)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Novo Nordisk A/S (Denmark)
  • Merck & Co., Inc. (US)
  • Celgene Corporation (US)
  • GlaxoSmithKline PLC (UK)
  • Gilead Sciences, Inc. (US)
  • Biogen Inc. (US)
  • AstraZeneca PLC (UK)
  • Takeda Pharmaceutical Company Limited (Japan)
  • Abbott Laboratories (US)
  • Bayer AG (Germany)
  • Alexion Pharmaceuticals Inc. (US)
  • Novartis AG (Switzerland)
  • Sanofi (France)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Protein Therapeutics Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Protein Therapeutics Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Protein Therapeutics Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Protein Therapeutics Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Protein Therapeutics Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Protein Therapeutics Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Protein Therapeutics Market size was valued at USD 6.57 billion in 2022 and is poised to grow from USD 6.96 billion in 2023 to USD 11.10 billion by 2031, growing at a CAGR of 6% during the forecast period (2024-2031).

The aggressive environment of the Protein Therapeutics market is dynamic and characterised with the aid of the presence of key gamers and a dynamic interaction of innovation and strategic collaborations. The market also sees contributions from emerging biotech corporations centered on developing novel protein-based total capsules, fostering a weather of continuous studies and improvement. Strategic partnerships, mergers, and acquisitions are not unusual techniques hired to beautify product pipelines and extend market reach. Additionally, biosimilar opposition is intensifying, as businesses goal to provide cost-effective alternatives to installed protein therapeutics. 'Amgen Inc. (US)', 'AbbVie Inc. (US)', 'Roche Diagnostics (Switzerland)', 'Eli Lilly and Company (US)', 'Johnson & Johnson (US)', 'Pfizer Inc. (US)', 'F. Hoffmann-La Roche Ltd (Switzerland)', 'Novo Nordisk A/S (Denmark)', 'Merck & Co., Inc. (US)', 'Celgene Corporation (US)', 'GlaxoSmithKline PLC (UK)', 'Gilead Sciences, Inc. (US)', 'Biogen Inc. (US)', 'AstraZeneca PLC (UK)', 'Takeda Pharmaceutical Company Limited (Japan)', 'Abbott Laboratories (US)', 'Bayer AG (Germany)', 'Alexion Pharmaceuticals Inc. (US)', 'Novartis AG (Switzerland)', 'Sanofi (France)'

The growing prevalence of continual illnesses and complicated clinical conditions, for which protein-primarily based treatment options provide targeted and effective treatment options. The versatility of protein therapeutics, such as monoclonal antibodies and other biologics, allows precise interventions in numerous healing regions, which includes oncology, immunology, and metabolic problems. Additionally, improvements in biotechnology and genetic engineering have facilitated the development of revolutionary and stronger protein therapeutics. The growing trend closer to personalized remedy and the call for biopharmaceuticals with fewer side results similarly stimulate the adoption of protein-based totally remedies.

Rising Emphasis on Personalized Medicine: The growing emphasis on personalised remedy, with a growing attention on developing focused protein therapeutics tailor-made to individual affected person profiles. The rise of subsequent-technology biologics, consisting of antibody-drug conjugates and bispecific antibodies, underscores a trend towards more potent and versatile therapeutic modalities. Furthermore, improvements in protein engineering technology are facilitating the layout of novel and optimized protein systems, enhancing healing efficacy. The exploration of opportunity management routes, which include subcutaneous and oral transport, is gaining traction, presenting progressed affected person convenience.

North America is likely to dominate the Protein Therapeutics market. This dominance is attributed to the area's properly-set up biopharmaceutical industry, enormous studies and development sports, and a high incidence of chronic illnesses. The presence of key marketplace players and a robust healthcare infrastructure in addition contribute to North America's leadership within the Protein Therapeutics marketplace.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Protein Therapeutics Market

Product ID: SQMIG35H2238

$5,300
BUY NOW GET FREE SAMPLE